| Literature DB >> 31839717 |
Vanessa Da Costa1, Rosine Ingabire1, Robertine Sinabamenye1, Etienne Karita1, Victoria Umutoni2, Alexandra Hoagland1, Susan Allen2, Ellen Mork3, Rachel Parker1, Jeannine Mukamuyango1, Lisa Haddad2, Julien Nyombayire1, Kristin M Wall2.
Abstract
BACKGROUND: The desire to space or prevent future pregnancies is high among postpartum women in Rwanda. However, the use of long-acting reversible contraception (LARC), especially the highly effective and cost-effective copper intrauterine device (IUD), is very low, whereas the rates of unintended pregnancy are high. This study aims to identify factors associated with pregnant women's and couple's interest in receiving a postpartum intrauterine device (PPIUD) within 6 weeks after delivery.Entities:
Keywords: Antenatal Care; Family Planning; Intrauterine Device; Long-Acting Reversible Contraception; Postpartum IUD
Year: 2019 PMID: 31839717 PMCID: PMC6893932 DOI: 10.1177/1179558119886843
Source DB: PubMed Journal: Clin Med Insights Reprod Health ISSN: 1179-5581
Figure 1.Enrollment and PPIUD interest within 6 weeks after delivery. PPIUD indicates postpartum intrauterine device.
Demographic and behavioral characteristics of women with or without their male partners stratified by PPIUD interest within 6 weeks after delivery.
| Characteristics | Women with or without male partner (n = 150) | ||||
|---|---|---|---|---|---|
| PPIUD interest = Yes; n = 124 | PPIUD interest = No; n = 26 | ||||
| Median | IQR | Median | IQR | ||
| Age | |||||
| Female | 28 | 8 | 30 | 7 | 0.97 |
| Male | 31 | 8 | 30 | 8 | 0.99 |
| Household monthly income (US$)[ | 24 | 113.10 | 1 | 60 | .27 |
| Pregnancy and birth spacing | |||||
| Gestational age (months) | 7 | 3 | 8 | 1 | .03 |
| Number of current children[ | 1 | 2 | 2 | 3 | .48 |
| Number of children who were planned[ | 2 | 2 | 2 | 2 | .14 |
| Age of youngest child | 3 | 4 | 3 | 2 | .74 |
| Desired number of additional children | 1 | 2 | 1 | 2 | .41 |
| Desired years until next child | 5 | 3 | 5 | 4 | .69 |
| n | % | n | % | ||
| Location | .86 | ||||
| Kinyinya Health Center | 20 | 16 | 5 | 19 | |
| Remera Health Center | 21 | 17 | 4 | 15 | |
| Kacyiru Health Center and Hospital | 43 | 35 | 7 | 27 | |
| Muhima Health Center and Hospital | 40 | 32 | 10 | 38 | |
| Cohabitation | .38 | ||||
| Yes | 117 | 94 | 23 | 88 | |
| No | 7 | 6 | 3 | 12 | |
| Education (Female) | 0.20 | ||||
| Secondary school and college/university | 65 | 52 | 10 | 38 | |
| No School and Primary School | 59 | 48 | 16 | 62 | |
| Religion (Female) | 0.20 | ||||
| Catholic | 31 | 25 | 3 | 12 | |
| NonCatholic | 93 | 75 | 23 | 88 | |
| Occupation (Female) | 0.32 | ||||
| Employed | 56 | 45 | 9 | 35 | |
| Unemployed | 68 | 55 | 17 | 65 | |
| Literacy (Female) | 0.16 | ||||
| Read Kinyarwanda | 112 | 90 | 21 | 81 | |
| Yes | 12 | 10 | 5 | 19 | |
| No | |||||
| Write Kinyarwanda | 111 | 90 | 21 | 81 | .21 |
| Yes | 13 | 10 | 5 | 19 | |
| No | |||||
| Mutuelle health insurance (Female) | 0.68 | ||||
| Yes | 116 | 94 | 24 | 92 | |
| No | 8 | 6 | 2 | 8 | |
| Education (Male) | 0.71 | ||||
| Secondary school and college/University | 16 | 41 | 4 | 50 | |
| No school and primary school | 23 | 59 | 4 | 50 | |
| Religion (Male) | 0.71 | ||||
| Catholic | 19 | 49 | 3 | 38 | |
| NonCatholic | 20 | 51 | 5 | 63 | |
| Occupation (Male) | 0.31 | ||||
| Employed | 38 | 97 | 7 | 88 | |
| Unemployed | 1 | 3 | 1 | 13 | |
| Literacy (Male) | |||||
| Read Kinyarwanda | .54 | ||||
| Yes | 36 | 92 | 7 | 88 | |
| No | 3 | 8 | 1 | 13 | |
| Write Kinyarwanda | 1.00 | ||||
| Yes | 34 | 87 | 7 | 88 | |
| No | 5 | 13 | 1 | 13 | |
| Mutuelle health insurance (Male) | 0.67 | ||||
| Yes | 30 | 77 | 7 | 88 | |
| No | 9 | 23 | 1 | 13 | |
| Previously used modern methods[ | |||||
| IUD | .59 | ||||
| Yes | 5 | 4 | 0 | 0 | |
| No | 119 | 96 | 26 | 100 | |
| Implant | .53 | ||||
| Yes | 22 | 18 | 6 | 23 | |
| No | 102 | 82 | 20 | 77 | |
| Injectables | .87 | ||||
| Yes | 45 | 36 | 9 | 35 | |
| No | 79 | 64 | 17 | 65 | |
| Oral contraceptive pills | .07 | ||||
| Yes | 30 | 24 | 2 | 8 | |
| No | 94 | 76 | 24 | 92 | |
| None | .50 | ||||
| Never used a modern method | 53 | 43 | 13 | 50 | |
| Used at least 1 modern method | 71 | 57 | 13 | 50 | |
| Previously used LARC methods | .81 | ||||
| Yes | 26 | 21 | 6 | 23 | |
| No | 98 | 79 | 20 | 77 | |
| Male partner present | 1.00 | ||||
| Yes | 39 | 31 | 8 | 31 | |
| No | 85 | 69 | 18 | 69 | |
Abbreviations: LARC, long-acting reversible contraception; PPIUD, postpartum intrauterine device; RWF, Rwandan Francs.
Income converted from Rwandan Francs to USD using rate at time of data collection $1 = 840 RWF.
Not including current pregnancy.
Participants could choose more than 1 contraceptive method.
P < .05.
Unprompted benefits and disadvantages of the PPIUD reported by women with or without their male partners stratified by PPIUD interest within 6 weeks after delivery.
| Knowledge | Women- with or without male partner (n = 150) | ||||
|---|---|---|---|---|---|
| PPIUD interest = Yes; n = 124 | PPIUD interest = No; n = 26 | ||||
| n | % | n | % | ||
| Benefits[ | |||||
| No hormones | 90 | 73 | 9 | 35 | .0002 |
| Pregnancy prevention effectiveness[ | 77 | 62 | 12 | 46 | .13 |
| Long-term method | 71 | 57 | 5 | 19 | .0004 |
| Delays pregnancy/birth spacing | 40 | 32 | 11 | 42 | .33 |
| None/do not know | 20 | 16 | 12 | 46 | .0007 |
| Ease of logistics[ | 13 | 10 | 4 | 15 | .50 |
| Immediately fertile again after removal | 7 | 6 | 0 | 0 | .61 |
| Disadvantages[ | |||||
| Unintended pregnancy | 50 | 40 | 7 | 27 | .20 |
| None/do not know | 48 | 39 | 9 | 35 | .70 |
| Irregular/heavy bleeding | 23 | 19 | 3 | 12 | .57 |
| Expulsion | 17 | 14 | 1 | 4 | .20 |
| Physical side effects[ | 8 | 6 | 8 | 31 | .0003 |
| Infection | 9 | 7 | 6 | 23 | .01 |
| Cancer/cysts | 12 | 10 | 2 | 8 | 1.00 |
| Sexual and other concerns[ | 8 | 6 | 1 | 4 | 1.00 |
| Ectopic pregnancy | 5 | 4 | 3 | 12 | .14 |
Abbreviations: PPIUD, postpartum intrauterine device.
Unprompted open ended questions.
Prevent pregnancy, effective immediately after insertion, highly effective, most effective at preventing pregnancy, cost-effective.
Easy to use, easy to get, reduces appointment times, can easily go back to work, does not have disadvantages of other methods.
Side effects in general, headache, backache, weight gain/loss, abdominal pain, vaginal dryness, negatively affect the body.
Affects sexual intercourse, no hormones, concerned about IUD string, IUD disappears.
P < .05.
Unadjusted OR and 95% CI for factors associated with PPIUD interest within 6 weeks after delivery.
| Variables | Women with or without male partner (n = 150) | ||
|---|---|---|---|
| OR | 95% CI | ||
| Gestational age (months) | 0.71 | 0.53-0.96 | .02 |
| Self-reported no hormones as a benefit | |||
| No | 1.00 | — | |
| Yes | 5.00 | 2.04-12.29 | .0005 |
| Self-reported long-term method as a benefit | |||
| No | 1.00 | — | |
| Yes | 5.63 | 1.99-15.89 | .001 |
| Self-reported no benefits or do not know benefits | |||
| No | 1.00 | — | |
| Yes | 0.22 | 0.09-0.56 | .001 |
| Self-reported physical side effects as a disadvantage[ | |||
| No | 1.00 | — | |
| Yes | 0.16 | 0.05-0.47 | .001 |
| Self-reported infection as a disadvantage | |||
| No | 1.00 | — | |
| Yes | 0.26 | 0.08-0.81 | .02 |
Abbreviations: CI, confidence interval; OR, odds ratio; PPIUD, postpartum intrauterine device.
Side effects in general, headache, backache, weight gain/loss, abdominal pain, vaginal dryness, negatively affect the body.
P < .05.
Adjusted odds ratio (aOR) and 95% confidence interval (CI) for factors associated with PPIUD interest within 6 weeks after delivery.
| Variables | Women with or without male partner (n = 150) | ||
|---|---|---|---|
| aOR[ | 95% CI | ||
| Gestational age (mo) | 0.81 | 0.58-1.11 | .19 |
| Self-reported no hormones as a benefit | |||
| No | 1.00 | — | |
| Yes | 2.94 | 0.67-12.91 | .15 |
| Self-reported long-term method as a benefit | |||
| No | 1.00 | — | |
| Yes | 2.03 | 0.53-7.88 | .30 |
| Self-reported no benefits or do not know benefits | |||
| No | 1.00 | — | |
| Yes | 0.54 | 0.13-2.30 | .40 |
| Self-reported physical side effects as a disadvantage[ | |||
| No | 1.00 | — | |
| Yes | 0.21 | 0.06-0.75 | .02 |
| Self-reported infection as a disadvantage | |||
| No | 1.00 | — | |
| Yes | 0.19 | 0.04-0.85 | .03 |
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; IUD: intrauterine device.
Adjusted for all the other variables in the table.
Side effects in general, headache, backache, weight gain/loss, abdominal pain, vaginal dryness, negatively affect the body.
P < .05.